Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

measurable disease
invasive breast cancer
estrogen
stage iv breast cancer
whole brain radiotherapy
  • 8 views
  • 19 Feb, 2024
  • 1 location
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

formalin-fixed paraffin-embedded
major surgery
endometrial cancer
measurable disease
carcinoma
  • 0 views
  • 19 Feb, 2024
  • 1 location